To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

NCT00947128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea
Vomiting

Interventions

DRUG: Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)
DRUG: Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline)

Sponsor

Sandoz